Literature DB >> 20417661

Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort.

R Ivanova Georgieva1, M V García López, J Ruiz-Morales, F J Martínez-Marcos, J M Lomas, A Plata, M Noureddine, C Hidalgo-Tenorio, J M Reguera, J De la Torre Lima, J Gálvez Aceval, M Márquez, A de Alarcón.   

Abstract

SUMMARY
OBJECTIVE: To evaluate the current trends in the clinical characteristics and the prognosis of Streptococcus agalactiae infective endocarditis (IE), uncommon disease associated with high mortality.
METHODS: Descriptive analysis of 27 cases of a large cohort (961 episodes) of infective endocarditis collected in seven hospitals of Andalusia (Spain) between 1984 and 2008.
RESULTS: Native valves were affected in most cases (85. 2%), multiple valves were frequently involved (22.2%). The median age of the patients was 65 (51-76) years (59.3% men), with a comorbidity, according to the Charlson index, of 2.6+/-2.3. The most frequent underlying diseases were diabetes mellitus (25.9%), chronic obstructive pulmonary disease (14.8%), neoplasms (14.8%), urological disorders (11%) and chronic liver disease (11%). Clinical presentation was characterized by rapid worsening (median of 9 (5.7-15) days from onset of symptoms until diagnosis), a high rate of embolisms (37%) and cardiac complications (abscesses, fistulas or valve rupture) - 37% of cases. Surgery was performed in 12 patients (44.4%) and a high mortality (40.7%) was observed.
CONCLUSION: S. agalactiae IE is a serious disease with aggressive course and high mortality rate and affects patients with debilitating diseases. We must be alert of the development of complications and consider early valve surgery when it is necessary. Copyright (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20417661     DOI: 10.1016/j.jinf.2010.04.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy?

Authors:  Salvatore Patanè
Journal:  J Cardiovasc Transl Res       Date:  2014-02-25       Impact factor: 4.132

2.  Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?

Authors:  Salvatore Patanè
Journal:  J Cardiovasc Transl Res       Date:  2014-02-25       Impact factor: 4.132

3.  Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.

Authors:  Min Joo Choi; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim; Shun-Mei Lin; Yong Zhi; Jae Hyang Lim; Sangyong Lim; Ho Seong Seo; Joon Young Song
Journal:  Hum Vaccin Immunother       Date:  2017-10-30       Impact factor: 3.452

4.  Infectious native valve endocarditis by Streptococcus agalactiae species: Case report of pathogen identification only through metagenomic sequencing technology.

Authors:  Ruoxin Wang; Xuejie Cao; Fang Wu; Jinlong Zhao; Liang Fu; Ziming Yuan; Yinkai Ni; Zonghui Chen; Feng Li
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

5.  Streptococcus agalactiae endocarditis presenting as acalculous cholecystitis in a previously well woman.

Authors:  Linda Brewer; Amanda Hanora Lavan; Laura Cullen; Joseph Duggan
Journal:  BMJ Case Rep       Date:  2013-02-11

6.  Infective Endocarditis due to Streptococcus Agalactiae in Young and Immunocompetent Woman: A Case of Structurally Normal Valve Endocarditis Presented with Major Stroke.

Authors:  Min Ju Song; Won Ho Kim; Sun Hwa Lee; Sang Rok Lee; Kyoung-Suk Rhee; Jei Keon Chae; Jae Ki Ko
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

Review 7.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

8.  Advantages and limitations of ribosomal RNA PCR and DNA sequencing for identification of bacteria in cardiac valves of danish patients.

Authors:  Michael Kemp; Jette Bangsborg; Anne Kjerulf; Thomas Andersen Schmidt; John Christensen; Akhmadjon 6 Irmukhamedov; Niels Eske Bruun; Rimtas Dargis; Keld Andresen; Jens Jørgen Christensen
Journal:  Open Microbiol J       Date:  2013-12-27

9.  Role of the serine-rich surface glycoprotein Srr1 of Streptococcus agalactiae in the pathogenesis of infective endocarditis.

Authors:  Ho Seong Seo; Yan Q Xiong; Paul M Sullam
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

10.  Aortic valve streptococcus group B endocarditis post-extracorporeal shock wave lithotripsy.

Authors:  Mohsen Meidani; Mahboobeh Taghavi; Morteza Abdar Esfahani
Journal:  ARYA Atheroscler       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.